FINWIRES · TerminalLIVE
FINWIRES

最新消息:渾水和卡利斯托發布做空報告後,Sportradar Group股價下跌

-- (第四段更新了Sportradar的回應。) 週三,渾水研究公司(Muddy Waters Research)和卡利斯托研究公司(Callisto Research)發布做空Sportradar集團(SRAD)的報告後,該公司股價暴跌超過23%。 渾水研究公司的報告稱,Sportradar「積極協助並教唆全球黑市和灰色市場的非法賭博活動——這並非偶然或疏忽,而是其商業策略」。該公司估計,目前非法營運商的收入約佔其總收入的20%至40%。 同樣做空Sportradar的卡利斯托研究公司表示,透過對數百個賭博平台的調查,該公司發現有證據表明,超過270個平台正在使用Sportradar的產品或服務,或明確聲稱正在使用,而「這些平台在受監管或被禁止的賭博市場中非法運作」。該公司還補充說,其中相當一部分運營商根本沒有任何許可證。 Sportradar 告訴:「今天發布的一份簡短報告包含有關公司的事實錯誤,我們明確否認這些說法。」該公司還補充說,該公司只與獲得許可的運營商合作,並遵循嚴格的全球合規和盡職調查標準。

Price: $12.82, Change: $-4.02, Percent Change: -23.87%

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL